Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Current Assets (2023 - 2025)

Historic Current Assets for CG Oncology (CGON) over the last 3 years, with Q3 2025 value amounting to $695.8 million.

  • CG Oncology's Current Assets rose 2603.06% to $695.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $695.8 million, marking a year-over-year increase of 2603.06%. This contributed to the annual value of $754.2 million for FY2024, which is 28851.97% up from last year.
  • Per CG Oncology's latest filing, its Current Assets stood at $695.8 million for Q3 2025, which was up 2603.06% from $673.0 million recorded in Q2 2025.
  • In the past 5 years, CG Oncology's Current Assets ranged from a high of $754.2 million in Q4 2024 and a low of $194.1 million during Q4 2023
  • Its 3-year average for Current Assets is $589.1 million, with a median of $625.8 million in 2024.
  • Its Current Assets has fluctuated over the past 5 years, first skyrocketed by 28851.97% in 2024, then soared by 1936.03% in 2025.
  • Over the past 3 years, CG Oncology's Current Assets (Quarter) stood at $194.1 million in 2023, then surged by 288.52% to $754.2 million in 2024, then decreased by 7.75% to $695.8 million in 2025.
  • Its Current Assets was $695.8 million in Q3 2025, compared to $673.0 million in Q2 2025 and $701.2 million in Q1 2025.